Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

Cited by (772)

Items 301–400 of 772

1. The Mexican consensus on nonalcoholic fatty liver disease
   Raúl Bernal-Reyes, Graciela Castro‐Narro, René Malé-Velázquez, Ramón Carmona-Sánchez, M.S. González-Huezo, Ignacio García-Juárez, Norberto Carlos Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia et al. · 2019 · Revista de Gastroenterología de México (English Edition)
2. Diagnostic accuracy of combined biomarker measurements and vibration-controlled transient elastography (VCTE) for predicting fibrosis stage of non-alcoholic fatty liver disease
   Toshihide Shima, Kyoko Sakai, Hirohisa Oya, Takayuki Katayama, Yasuhide Mitsumoto, Masayuki Mizuno, Yoshihiro Kanbara, Takeshi Okanoue · 2019 · Journal of Gastroenterology
3. Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
   Taeang Arai, Masanori Atsukawa, Akihito Tsubota, Keizo Kato, Hiroshi Abe, Hirotaka Ono, Tadamichi Kawano, Yuji Yoshida, Tomohide Tanabe, Tomomi Okubo et al. · 2021 · Scientific Reports
4. NAFLD as a continuous driver in the whole spectrum of vascular disease
   Wei Li, Jiayi Liu, Jingjing Cai, Xiao‐Jing Zhang, Peng Zhang, Zhi‐Gang She, Shaoze Chen, Hongliang Li · 2021 · Journal of Molecular and Cellular Cardiology
5. Prevalence and risk factors for biopsy‐proven non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones
   Carmelo García‐Monzón, Javier Vargas‐Castrillón, José Luis Porrero Carro, María Teresa Alonso, Óscar Bonachía, María José Castillo, Alberto Marcos, Esther Quirós, Beatriz Ramos, Carlos Sánchez‐Cabezudo et al. · 2015 · Liver International
6. Efficacy and safety of oral semaglutide in patients with non-alcoholic fatty liver disease complicated by type 2 diabetes mellitus: a pilot study
   Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Ono, Hirotaka, Kawano, Tadamichi, Yoshida, Yuji, Okubo, Tomomi, Hayama, Korenobu, Nakagawa‐Iwashita, Ai, Itokawa, Norio et al. · 2022 · JGH Open
7. Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality
   Stefano Ballestri, Alessandro Mantovani, Maria Di Girolamo, Enrica Baldelli, Mariano Capitelli, Amedeo Lonardo · 2023 · Metabolism and Target Organ Damage
8. Liver Fibrosis Assessed Via Noninvasive Tests Is Associated With Incident Heart Failure in a General Population Cohort
   Theresa Hydes, Oliver John Kennedy, Kate Glyn‐Owen, Ryan Malcolm Buchanan, Julie Parkes, Daniel James Cuthbertson, Paul Roderick, Christopher D. Byrne · 2024 · Clinical Gastroenterology and Hepatology
9. PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
   Quelson Coelho Lisboa, Mateus Jorge Nardelli, Patrícia de Araújo Pereira, Débora Marques de Miranda, Stephanie Nunes Ribeiro, Raíssa Soares Neves da Costa, Camila Azevedo Versiani, Paula Vieira Teixeira Vidigal, Teresa Cristina Abreu Ferrari, Cláudia Alves Couto · 2020 · World Journal of Hepatology
10. Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver disease
    Ian A.C. Rowe · 2017 · The Lancet. Gastroenterology & hepatology
11. Non‐alcoholic fatty liver disease ( NAFLD ) fibrosis score predicts 6.6‐year overall mortality of C hinese patients with NAFLD
    Yunhao Xun, Jian‐chun Guo, Guo‐qiang Lou, Yanming Jiang, Zhenjie Zhuang, Mengfei Zhu, Yan Luo, Xiaojie Ma, Jing Liu, Dongxue Bian et al. · 2014 · Clinical and Experimental Pharmacology and Physiology
12. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
    Giulio Marchesini, Elisabetta Bugianesi, Patrizia Burra, Fabio Marra, Luca Miele, Anna Alisi, Piero Vajro, Mario Masarone, Salvatore Petta, Marcello Persico et al. · 2021 · Digestive and Liver Disease
13. Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity
    Wijarnpreecha, Karn, Panjawatanan, Panadeekarn, Aby, Elizabeth, Ahmed, Aijaz, Kim, Donghee · 2019 · Maturitas
14. Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease
    Yue Wang, Sherlot Juan Song, Yichong Jiang, Jimmy Che‐To Lai, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip · 2024 · Clinical and Molecular Hepatology
15. Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC
    Ken Liu, Geoffrey William McCaughan · 2018 · Advances in experimental medicine and biology
16. Weight gain during early adulthood, trajectory of body shape and the risk of nonalcoholic fatty liver disease: A prospective cohort study among women
    Mi Na Kim, Chun‐Han Lo, Kathleen E. Corey, Po‐Hong Liu, Wenjie Ma, Xuehong Zhang, Manol Jovani, Mingyang Song, Andrew Tan Chan, Tracey G. Simon · 2020 · Metabolism
17. A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis
    Rieko Bessho, Kazuhiro Kashiwagi, Akihiko Ikura, Karin Yamataka, Jun Inaishi, Hiromasa Takaishi, Takanori Kanai∥ · 2022 · PLoS ONE
18. Association between non-alcoholic fatty liver disease and coronary artery disease outcomes: A systematic review and meta-analysis
    Hazem Maarouf Abosheaishaa, Mai Hussein, Muhammad Ghallab, Magdy Abdelhamid, Natalie Balassiano, Md Ripon Ahammed, Muhammad Almas Baig, Jawad Sajid Khan, Moaz Elshair, Moataz Yousry Soliman et al. · 2024 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
19. Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)
    Golabi, Pegah, Stepanova, Maria, Pham, Huong T, Cable, Rebecca, Rafiq, Nila, Bush, Haley, Gogoll, Trevor, Younossi, Zobair M · 2018 · BMJ Open Gastroenterology
20. Association between depression and metabolic dysfunction-associated fatty liver disease/significant fibrosis
    Donghee Kim, Brittany Burns Dennis, George T. Cholankeril, Aijaz Ahmed · 2023 · Journal of Affective Disorders
21. Association Between Noninvasive Liver Fibrosis Scores and Heart Failure in a General Population
    Xiao Liu, H T Zhang, Chang‐Chang Fang, Lin Li, Ze-Qun Lai, Ning‐Peng Liang, Xiang‐Tao Zhang, Min Wu, Xiaoping Yin, Huang Zhang et al. · 2024 · Journal of the American Heart Association
22. Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia
    Hugo Perazzo, Mona Munteanu, Yen Ngo, Pascal Lebray, N. Seurat, F. Rutka, M. Couteau, Sophie Jacqueminet, Philippe Giral, Denis Monneret et al. · 2014 · Alimentary Pharmacology & Therapeutics
23. The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort study
    Veeravich Jaruvongvanich, Karn Wijarnpreecha, Patompong Ungprasert · 2017 · Clinics and Research in Hepatology and Gastroenterology
24. Low‐fasting triglyceride levels are associated with non‐invasive markers of advanced liver fibrosis among adults in the United States
    Zhenghui Gordon Jiang, Yusuke Tsugawa, Elliot B. Tapper, Michelle Lai, Nezam H. Afdhal, Simon Christopher Robson, Kenneth Jay Mukamal · 2015 · Alimentary Pharmacology & Therapeutics
25. Endogenous sex hormones and nonalcoholic fatty liver disease in US adults
    Donghee Kim, Richie Manikat, George T. Cholankeril, Aijaz Ahmed · 2023 · Liver International
26. Predictors of malignancies and overall mortality in J apanese patients with biopsy‐proven non‐alcoholic fatty liver disease
    Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Hiroyoshi Taketani, Kazuyuki Kanemasa, Hiroshi Ishiba, Akira Okajima, Takeshi Nishimura, Kanji Yamaguchi, Michihisa Moriguchi et al. · 2014 · Hepatology Research
27. The Natural History of NAFLD, a Community-Based Study at a Large Health Care Delivery System in the United States
    Lisa M. Nyberg, Craig T. Cheetham, Heather M. Patton, Su-Jau Yang, Kevin M. Chiang, Susan L. Caparosa, Julie A. Stern, Anders H. Nyberg · 2020 · Hepatology Communications
28. Advanced liver fibrosis and the metabolic syndrome in a primary care setting
    Andrew D. Schreiner, Jingwen Zhang, Valerie L. Durkalski‐Mauldin, Sherry Livingston, Justin E. Marsden, John Bian, Patrick D. Mauldin, William P. Moran, Don C. Rockey · 2021 · Diabetes/Metabolism Research and Reviews
29. Liver stiffness (Fibroscan®) is a predictor of all‐cause mortality in people with non‐alcoholic fatty liver disease
    Michael Rudi Braude, Stuart Keith Roberts, Ammar Majeed, John Samuel Lubel, Jirayut Prompen, Anouk T Dev, William Sievert, Stephen Bloom, Paul John Gow, William W. Kemp · 2022 · Liver International
30. Association between Cardiovascular Disease and Liver Disease, from a Clinically Pragmatic Perspective as a Cardiologist
    Mitsutaka Nakashima, Kazufumi Nakamura, Takahiro Nishihara, Keishi Ichikawa, Rie Nakayama, Yoichi Takaya, Norihisa Toh, Satoshi Akagi, Toru Miyoshi, Teiji Akagi et al. · 2023 · Nutrients
31. Up-to-date global epidemiology of nonalcoholic fatty liver disease
    Richie Manikat, Aijaz Ahmed, Donghee Kim · 2023 · HepatoBiliary Surgery and Nutrition
32. Updated S2k clinical practice guideline on non-alcoholic fatty liver disease (NAFLD) issued by the German society of gastroenterology, digestive and metabolic diseases (DGVS)–April 2022–AWMF Registration No.: 021–025
    Authors, Collaborators: · 2022 · Zeitschrift für Gastroenterologie
33. The Association Between Nonalcoholic Fatty Liver Disease and Risk of Cardiovascular Disease, Stroke, and Extrahepatic Cancers
    Nicolette Veracruz, Bilal Hameed, Sammy Saab, Robert J. Wong · 2020 · Journal of Clinical and Experimental Hepatology
34. Nonalcoholic Fatty Liver Disease-Evidence for a Thrombophilic State?
    Margaret Spinosa, Jonathan G. Stine · 2020 · Current Pharmaceutical Design
35. Association of coronary artery calcification with liver fibrosis in Japanese patients with non‐alcoholic fatty liver disease
    Hiroshi Ishiba, Yoshio Sumida, Seita Kataoka, Masaaki Kuroda, Satoshi Akabame, Ki-ichiro Tomiyasu, Muhei Tanaka, Masahiro Arai, Hiroyoshi Taketani, Yuya Seko et al. · 2016 · Hepatology Research
36. Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people
    Antonio De Vincentis, Luisa Costanzo, Umberto Vespasiani Gentilucci, Antonio Picardi, Stefania Bandinelli, Luigi Ferrucci, Raffaele Antonelli Incalzi, Claudio Pedone · 2019 · Digestive and Liver Disease
37. Long-term Liver-related Outcomes of Patients With Chronic Liver Diseases in Australia
    Yi Huang, John Joseph, W. Bastiaan de Boer, Wendy Cheng, Leon Anton Adams, Gerry C. MacQuillan, George Garas, Spiro Raftopoulos, Gary P. Jeffrey · 2019 · Clinical Gastroenterology and Hepatology
38. Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis
    Donghee Kim, Won Kyum Kim, Sae Kyung Joo, Jimin Han, Jung Ho Kim, Stephen A. Harrison, Zobair M. Younossi, Aijaz Ahmed · 2019 · Journal of Gastroenterology
39. The Changing Epidemiology of Liver Disease Among US Children and Adolescents From 1999 to 2016
    Jie Li, Michael Huan Le, Monique T. Barakat, Ramsey C Cheung, Mindie H. Nguyen · 2021 · The American Journal of Gastroenterology
40. Racial differences in prevalence and severity of non-alcoholic fatty liver disease
    Maurizio Bonacini, Farah Kassamali, Swathi Kari, Nieves Lopez Barrera, Mohamed Kohla · 2021 · World Journal of Hepatology
41. Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease
    Seogsong Jeong, Yun Hwan Oh, Seulggie Choi, Jooyoung Chang, Sung Min Kim, Joung Sik Son, Gyeongsil Lee, Won Kyum Kim, Sang Min Park · 2021 · Gut and Liver
42. Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017–2018
    Julia Yang Payne, Naim Alkhouri, Phuc Le, Michael B. Rothberg, Prido Polanco, Celine Sakkal, Srinivasan Dasarathy · 2023 · Hepatology Communications
43. The Interactions of Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases
    Hugo Perazzo, Thierry Poynard, Jean‐François Dufour · 2013 · Clinics in Liver Disease
44. Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease
    Serkan Doğan, Mehmet Çelikbilek, Yunus Keser Yılmaz, Savaş Sarıkaya, Gökmen Zararsız, Halil İbrahim Serin, Elif Börekçi, Lütfi Akyol, İlyas Pırtı, Sena E. Davarci · 2015 · European Journal of Gastroenterology & Hepatology
45. High prevalence of non-alcoholic fatty liver disease in patients with inflammatory bowel disease receiving anti-tumor necrosis factor therapy
    Alisa Likhitsup · 2019 · Annals of Gastroenterology
46. Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease
    Samarth Siddharth Patel, Mohammad Shadab Siddiqui · 2018 · Drugs
47. PNPLA3 gene polymorphism and overall and cardiovascular mortality in the United States
    Karn Wijarnpreecha, Melissa Scribani, Pascale Raymond, Denise M. Harnois, Andrew Paul Keaveny, Aijaz Ahmed, Donghee Kim · 2020 · Journal of Gastroenterology and Hepatology
48. Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack
    Minyoul Baik, Hyo Suk Nam, Ji Hoe Heo, Hyungjong Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Hye Sun Lee et al. · 2020 · Cerebrovascular Diseases
49. Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis
    Sina Ghandian, Rahul Thapa, Anurag Garikipati, Gina Barnes, Abigail Green‐Saxena, Jacob S. Calvert, Qingqing Mao, Ritankar Das · 2022 · JGH Open
50. Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes
    Fu‐Shun Yen, Ming‐Chih Hou, James Cheng‐Chung Wei, Ying‐Hsiu Shih, Chii‐Min Hwu, Chih‐Cheng Hsu · 2024 · BMC Medicine
51. Hepatic Steatosis and Steatohepatitis: Are they Really Two Distinct Entities?
    Cory M. Fielding, Paul Angulo · 2014 · Current Hepatology Reports
52. Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease
    Saumya Jayakumar, Stephen A. Harrison, Rohit Seth Loomba · 2016 · Current Hepatology Reports
53. Assessment of 10‐year changes in liver stiffness using vibration‐controlled transient elastography in non‐alcoholic fatty liver disease
    Asako Nogami, Masato Yoneda, Takashi Kobayashi, Takaomi Kessoku, Yasushi Honda, Yuji Ogawa, Kaori Suzuki, Wataru Tomeno, Kento Imajo, Hiroyuki Kirikoshi et al. · 2019 · Hepatology Research
54. Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
    Eugene Han, Yong‐ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Byung‐Wan Lee, Eun Seok Kang et al. · 2022 · Gut and Liver
55. Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease
    Donghee Kim, Goh Eun Chung, Min‐Sun Kwak, Yoon Jun Kim, Jung‐Hwan Yoon · 2017 · Digestive and Liver Disease
56. The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease
    Jose Hernandez Roman, Mohammad Shadab Siddiqui · 2020 · Endocrinology Diabetes & Metabolism
57. Metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality among adults in the United States
    Donghee Kim, Karn Wijarnpreecha, George T. Cholankeril, Aijaz Ahmed · 2023 · Journal of Hepatology
58. Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis
    Atilla Engin · 2024 · Advances in experimental medicine and biology
59. Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis
    Sanjaya Kumar Satapathy, Pratik Banerjee, Joseph F. Pierre, Daleniece Higgins, Soma Dutta, Rajiv Prakash Heda, Sabrina D. Khan, Vamsee K. Mupparaju, Valeria R. Mas, Satheesh P. Nair et al. · 2020 · Transplantation Direct
60. Nonalcoholic Fatty Liver Disease and Its Complex Relation with Type 2 Diabetes Mellitus—From Prevalence to Diagnostic Approach and Treatment Strategies
    Cosmina-Theodora Diaconu, Cristian Guja · 2022 · Journal of Clinical Medicine
61. Healthy Lifestyle Is Associated with Reduced Mortality in Patients with Non-Alcoholic Fatty Liver Disease
    Chengxiao Yu, Jiaxin Gao, Xinyuan Ge, Xiao Wang, Yuqing Ding, Ting Tian, Xin Ping Xu, Wen Guo, Quanrongzi Wang, Zijun Ge et al. · 2022 · Nutrients
62. Chronic intake of high dietary sucrose induces sexually dimorphic metabolic adaptations in mouse liver and adipose tissue
    Erin J. Stephenson, Amanda Stayton, A. Sethuraman, Prahlad K. Rao, Allison C. Meyer, C. Gomes, Molly C. Mulcahy, Liam McAllan, Michelle A. Puchowicz, J. Pierre et al. · 2022 · Nature Communications
63. Aerobic capacity and exercise performance in nonalcoholic fatty liver disease
    Patrick W. Austin, Lynn H. Gerber, James M. Paik, Jillian Kallman Price, Carey Escheik, Zobair M. Younossi · 2019 · The Journal of Sports Medicine and Physical Fitness
64. Nonalcoholic Fatty Liver Disease and Renal Function Impairment: A Cross‐Sectional Population‐Based Study on Its Relationship From 1999 to 2016
    Michael Huan Le, Yee Hui Yeo, Linda L Henry, Mindie H. Nguyen · 2019 · Hepatology Communications
65. The Interplay Between Nonalcoholic Fatty Liver Disease and Atherosclerotic Heart Disease
    Samarth Siddharth Patel, Mohammad Shadab Siddiqui · 2018 · Hepatology
66. Sex differences in mortality and liver‐related events in non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
    Huimin Zhou, Haiyan Chen, Hanxiao Lu, Bo Wu, Shuo Zhang, Yuanlong Gu, Guangwen Zhou, Jie Xiang, Jun Yang · 2024 · Liver International
67. Association between systemic inflammation markers and cardiovascular mortality in adults with metabolic dysfunction-associated steatotic liver disease
    Ziqi Zhang, Weijie Zhang, Zhidong Liu, Jiayi Ou, Yunhong Sun, Li Zhang, Guang Ji · 2024 · Nutrition Metabolism and Cardiovascular Diseases
68. FIB-4 index-based surveillance for advanced liver fibrosis in diabetes patients
    Nozomi Kawata, Hirokazu Takahashi, Shinji Iwane, Kanako Inoue, Motoyasu Kojima, Michiko Kohno, Kenichi Tanaka, Hitoe Mori, Hiroshi Isoda, Satoshi Oeda et al. · 2020 · Diabetology International
69. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography
    Toshifumi Tada, Takashi Nishimura, Masahiro Yoshida, Hiroko Iijima · 2020 · Journal of Medical Ultrasonics
70. Prevalence of non-alcoholic fatty liver disease on computed tomography in patients with inflammatory bowel disease visiting an emergency department
    Alisa Likhitsup · 2019 · Annals of Gastroenterology
71. NAFLD: comorbidity and associated diseases
    Maria A. Livzan, Olga V. Gaus, N. A. Nikolaev, T. S. Krolevetz · 2020 · Экспериментальная и клиническая гастроэнтерология
72. Improvements in hepatic steatosis, obesity, and insulin resistance in adults with nonalcoholic fatty liver disease after the primary obesity surgery endoluminal 2.0 procedure
    AlKhatry, Maryam, Rapaka, Babusai, Maselli, Daniel B., Abboud, Donna Maria, Brunaldi, Vitor O., Mahmoud, Tala, Ghazi, Rabih, Abdul Razzak, Farah, Gala, Khushboo, Joudah, Imad et al. · 2023 · Endoscopy
73. Neurodegeneration in juvenile Iberian pigs with diet-induced nonalcoholic fatty liver disease
    Nicole Zeltser, Isabell Meyer, Gabriella V. Hernandez, Matthew J. Trahan, Rob K. Fanter, Mohammed Kotb Abo-Ismail, Hunter Glanz, Christine R. Strand, Douglas G. Burrin, Michael R. La Frano et al. · 2020 · American Journal of Physiology-Endocrinology and Metabolism
74. Utility of Multiparametric CT for Identification of High-Risk NAFLD
    Meghan G. Lubner, Peter M. Graffy, Adnan Said, Rao F. Watson, Ryan D. Zea, Kyle M. Malecki, Perry Joseph Pickhardt · 2021 · American Journal of Roentgenology
75. Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity: an observational study
    Silvia Bettini, Roberto Serra, Roberto Fabris, Chiara Dal Prà, Francesca Favaretto, Francesca Dassie, Claudio Duso, Roberto Vettor, Luca Busetto · 2021 · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
76. Novel metabolic phenotypes for extrahepatic complication of nonalcoholic fatty liver disease
    Jiayi Yi, Lili Wang, Jiajun Guo, Xiangpeng Ren · 2023 · Hepatology Communications
77. Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
    Kathryn Williams, DAVID R. SULLIVAN, Geoffrey C. Nicholson, Jacob George, Alicia Josephine Jenkins, Andrzej S. Januszewski, Val Gebski, Patrick John Manning, Yong Mong Tan, Mark W. Donoghoe et al. · 2015 · Metabolism
78. Impact of liver fibrosis score on prognosis in patients with previous myocardial infarction: A prospective cohort study
    Ye‐Xuan Cao, Meng Zhang, Hui‐Wen Zhang, Jing‐Lu Jin, Hui‐Hui Liu, Yan Zhang, Yuan‐Lin Guo, Na‐Qiong Wu, Cheng‐Gang Zhu, Rui‐Xia Xu et al. · 2021 · Liver International
79. Association of HSD17B13 and PNPLA3 With Liver Enzymes and Fibrosis in Hispanic/Latino Individuals of Diverse Genetic Ancestries
    Rutledge, Stephanie M., Soper, Emily R., Ma, Ning, Pejaver, Vikas, Friedman, Scott L., Branch, Andrea D., Kenny, Eimear E., Belbin, Gillian M., Abul-Husn, Noura S. · 2023 · Clinical Gastroenterology and Hepatology
80. Sarcopenia modifies the associations of nonalcoholic fatty liver disease with all-cause and cardiovascular mortality among older adults
    Xingxing Sun, Zhelong Liu, Fuqiong Chen, Tingting Du · 2021 · Scientific Reports
81. Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease
    Jincheng Wang, Tao Qin, Jin-Yu Sun, Shiwu Li, Lihua Cao, Xiaojie Lu · 2022 · Frontiers in Physiology
82. Non‐alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study
    Yang Won Min, Youngha Kim, Geum‐Youn Gwak, Seonhye Gu, Danbee Kang, Soo Jin Cho, Eliseo Güallar, Juhee Cho, Dong Hyun Sinn · 2017 · Journal of Gastroenterology and Hepatology
83. Liver Fibrosis is Associated with Ischemic Stroke Risk in Women but not Men: The REGARDS Study
    Neal S. Parikh, Insu Koh, Lisa B. VanWagner, Mitchell S.V. Elkind, Neil A. Zakai, Mary Cushman · 2021 · Journal of Stroke and Cerebrovascular Diseases
84. Identifying High-Risk NASH Patients: What We Know so Far
    Marten Schulz, Frank Tacke · 2020 · Hepatic Medicine Evidence and Research
85. Liver Fibrosis Marker and Postoperative Mortality in Patients Without Overt Liver Disease
    Shira Zelber‐Sagi, Vikas N. O’Reilly-Shah, Christine T. Fong, Dana Ivancovsky Wajcman, May J. Reed, Itay Bentov · 2022 · Anesthesia & Analgesia
86. Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease
    Hong Xia Fan, Lili Li, Zhenqiu Liu, Pengyan Zhang, Sheng Lan Wu, Xinyu Han, Xingdong Chen, Chen Suo, Liou Cao, Tiejun Zhang · 2023 · BMC Gastroenterology
87. Prevalence, trends, and characteristics of metabolic dysfunction-associated steatotic liver disease among the US population aged 12–79 years
    Tsung‐Hua Shen, Chung‐Hsuen Wu, Yuan‐Wen Lee, Chun‐Chao Chang · 2024 · European Journal of Gastroenterology & Hepatology
88. Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping
    Shahid Habib · 2024 · World Journal of Gastrointestinal Pathophysiology
89. Practical approach to non‐alcoholic fatty liver disease in patients with diabetes
    Foong Way David Tai, Wing‐Kin Syn, William Alazawi · 2015 · Diabetic Medicine
90. Association between the liver fat score (LFS) and cardiovascular diseases in the national health and nutrition examination survey 1999–2016
    Chun-On Lee, Hang‐Long Li, Man Fung Tsoi, Ching‐Lung Cheung, Bernard M.Y. Cheung · 2021 · Annals of Medicine
91. Nonalcoholic Fatty Liver Disease-Associated Liver Fibrosis Is Linked with the Severity of Coronary Artery Disease Mediated by Systemic Inflammation
    Ling-Zi Chen, Xubin Jing, Chaofen Wu, Yicheng Zeng, Yanchun Xie, Mu-qing Wang, Wenxia Chen, Xi Hu, Yanna Zhou, Xianbin Cai · 2021 · Disease Markers
92. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
    Associazione Italiana per lo Studio del Fegato (AISF), Società Italiana di Diabetologia (SID) and Società Italiana dell’Obesità (SIO) · 2021 · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
93. Diagnosis and Management of Heart Failure
    Inna P. Gladysheva, Ryan D. Sullivan · 2022 · MDPI eBooks
94. Higher NAFLD fibrosis score is associated with impaired eGFR.
    M. Hsieh, Kuan-Ta Wu, Yi-Yu Chen, Jeng-Fu Yang, Wen-Yi Lin, N. Chang, Chia-Yi Lin, Chao-Kuan Huang, Chao-Ling Wang, H. Chuang et al. · 2019 · Journal of the Formosan Medical Association = Taiwan yi zhi
95. Non-alcoholic fatty liver disease is not independently associated with Helicobacter pylori in a central European screening cohort
    Sarah Wernly, Bernhard Wernly, Georg Semmler, Andreas Völkerer, Richard Rezar, Lorenz Semmler, Felix Stickel, Elmar Stephan Aigner, David Niederseer, Christian Datz · 2022 · Minerva Medica
96. Association between nonalcoholic fatty liver disease and atrial fibrillation and other clinical outcomes: a meta-analysis
    Vikash Jaiswal, Song Peng Ang, Helen Ye Rim Huang, Navroop Kaur Momi, Maha Hameed, Sidra Naz, Nitya Batra, Angela Ishak, Neel Ajit Doshi, Asmita Gera et al. · 2023 · Journal of Investigative Medicine
97. Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity
    Seokhyung Kim, Hae Yeul Park, Hye Sun Lee, Kwon Soo Jung, Moon‐Hyoung Lee, Jong Hyun Jhee, Tae Hoon Kim, Jung Eun Lee, Hyung Jong Kim, Beom Seok Kim et al. · 2020 · Scientific Reports
98. Females, Hispanics and older individuals are at greatest risk of developing metabolic syndrome in the U.S.
    Brendan Campbell, María Emilia Fernández Aguilar, Taft P. Bhuket, Sharon Torres, Benny Liu, Robert J. Wong · 2016 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
99. Liver Fibrosis Is Associated With Hemorrhagic Transformation in Patients With Acute Ischemic Stroke
    Chengxiang Yuan, Yiting Ruan, Ya‐Ying Zeng, Hao-Ran Cheng, Qianqian Cheng, Yunbin Chen, Weilei He, Guiqian Huang, Jincai He · 2020 · Frontiers in Neurology
100. Stratifying individuals into non-alcoholic fatty liver disease risk levels using time series machine learning models
     Ofir Ben‐Assuli, Arie Jacobi, Orit Goldman, Shani Shenhar‐Tsarfaty, Ori Rogowski, David Zeltser, Itzhak Shapira, Shlomo A. Berliner, Shira Zelber‐Sagi · 2022 · Journal of Biomedical Informatics